Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Return on Assets (2016 - 2025)

Historic Return on Assets for Amicus Therapeutics (FOLD) over the last 17 years, with Q3 2025 value amounting to 0.02%.

  • Amicus Therapeutics' Return on Assets rose 1200.0% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 1200.0%. This contributed to the annual value of 0.07% for FY2024, which is 1300.0% up from last year.
  • Amicus Therapeutics' Return on Assets amounted to 0.02% in Q3 2025, which was up 1200.0% from 0.05% recorded in Q2 2025.
  • In the past 5 years, Amicus Therapeutics' Return on Assets registered a high of 0.02% during Q3 2025, and its lowest value of 0.35% during Q2 2022.
  • For the 5-year period, Amicus Therapeutics' Return on Assets averaged around 0.22%, with its median value being 0.26% (2023).
  • Its Return on Assets has fluctuated over the past 5 years, first tumbled by -600bps in 2022, then surged by 1600bps in 2025.
  • Over the past 5 years, Amicus Therapeutics' Return on Assets (Quarter) stood at 0.27% in 2021, then fell by -19bps to 0.32% in 2022, then surged by 38bps to 0.2% in 2023, then surged by 64bps to 0.07% in 2024, then surged by 77bps to 0.02% in 2025.
  • Its Return on Assets was 0.02% in Q3 2025, compared to 0.05% in Q2 2025 and 0.04% in Q1 2025.